Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessTreatment with nonbiologics, particularly methotrexate, is associated with impaired seroconversion following two BNT162b2 or AZD1222 vaccine doses, in patients with IMIDs. These findings are consistent with those of other published studies. While this could indicate reduced protection against COVID-19, the immunological parameters that correlate most closely with vaccine effectiveness need to be defined to reach this conclusion.
Ali Al‐Janabi, Amelle Ra, Zoe Littlewood, Amy Foulkes, H.J.A. Hunter, Hector Chinoy, Christopher A Moriarty, Kimme L Hyrich, Jimmy K. Limdi, Zenas Z N Yiu, Christopher Em Griffiths, Richard B. Warren (2022). The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. , 188(4), DOI: https://doi.org/10.1093/bjd/ljac109.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2022
Authors
12
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1093/bjd/ljac109
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
.webp){kind=avatar}
